Inquest Examines Mounjaro's Role in Grandmother's Death, Clarifies Medical Oversight
An inquest into the death of Caroline Savage, a 73-year-old grandmother, has clarified that medical professionals did not overly concentrate on her use of the weight-loss medication Mounjaro prior to her passing. The inquest, led by Norfolk area coroner Yvonne Blake, addressed concerns raised by Savage's family, who felt that doctors too readily attributed her symptoms to the drug's side effects. However, Blake stated that the medical team had explored other potential causes, such as pancreatitis and an aortic aneurysm, indicating a broader diagnostic approach.
Savage's family expressed their worries that her symptoms were dismissed due to her Mounjaro prescription, which she had been taking for lipedema, a condition characterized by painful fat accumulation in the limbs that does not respond to diet or exercise. Despite these concerns, the coroner emphasized that there was no evidence to suggest that the doctors were fixated on the medication. She noted that while Savage had been prescribed an increasing dose of Mounjaro, she had not yet administered the higher dosage at the time of her hospital visit.
The inquest revealed that Savage was admitted to the Norfolk and Norwich University Hospital on October 18, 2024, presenting with severe abdominal pain. Although paramedics noted signs of peritonism, doctors did not confirm this diagnosis. Following an ultrasound and normal blood test results, she was given pain relief and discharged. Tragically, Savage collapsed at home later that day and went into cardiac arrest.
Coroner Blake stated that she would communicate with the Norfolk and Norwich University Hospital and the East of England Ambulance Service regarding concerns about record-keeping and communication among the medical staff. However, she did not identify any systemic issues within the emergency department that would have contributed to Savage's undiagnosed condition at discharge.
Family members, including daughter Susannah Savage, voiced their belief that Mounjaro was too quickly identified as a potential cause of her mother's symptoms. They noted that while doctors considered other diagnoses, the weight-loss drug was prominently mentioned in discharge notes. The family continues to seek clarity on whether the medical team fully considered the implications of Savage's recent morphine administration when assessing her condition.
Emily Ansell, another daughter, described her mother as the heart of their family, emphasizing her vibrant social life and excitement about her future with the new medication. This inquest serves as a reminder of the complexities involved in diagnosing patients with multiple health issues, particularly when medications like Mounjaro are involved.




